Polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
44
NCT04239469
Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 15, 2020
Completion: Sep 15, 2020
Loading map...